Fresenius SE & Co. KGaA (FSNUY) is a publicly traded company in the Healthcare sector, operating within the Medical - Care Facilities industry. The company is headquartered in Bad Homburg vor der Höhe, Germany. The current CEO is Michael Sen.
FSNUY has IPO date of 2012-05-15, 175,202 full-time employees, listed on the Other OTC, a market capitalization of $119.41B.
Fresenius SE & Co. KGaA is a diversified healthcare company headquartered in Germany that provides products and services across dialysis, hospital operations, and outpatient medical care. The company operates through four main divisions: Fresenius Medical Care, which specializes in dialysis products and services for chronic kidney failure patients; Fresenius Kabi, which offers intravenous drugs, nutritional products, biosimilars, and medical devices for therapeutic care; Fresenius Helios, which operates a large network of hospitals and outpatient clinics across Germany and Spain along with fertility treatment centers; and Fresenius Vamed, which provides project management, planning, construction, and operational services for healthcare facilities. Founded in 1912, the company has established itself as a global healthcare leader serving patients with serious illnesses across multiple continents.
